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Heart failure and diabetes are both lifestyle diseases that 
currently represent a significant financial strain at $245 Billion and 
$31 Billion respectively (Heidenreich, et al, 2013). Research 
indicates that the two diseases potentially exacerbate each other 
when comorbid. Early research indicates that lowering average 
blood sugar over time (1% a1C reduction) improves functional 
status, kidney function, and reduces Renin Angiotensin 
Aldosterone System activity in patients also suffering from CHF, 
changes that are also shown to improve management of heart 
failure (Lapina, et al, 2008.)
Little data was found to demonstrate short term efficacy of 
reducing average blood sugar in the inpatient population during 
exacerbation of either comorbidity. It is known that patients with 
diabetes have a considerably higher likelihood of comorbid heart 
failure when compared with those without (Wang, et al, 2015.) 
both of which are of clinical significance in the inpatient 
population.
One component of heart failure management in an inpatient 
encounter is diuretic interventions to reduce fluid volume 
overload. Diuretic therapy removes excess fluid and promotes 
patients to urinate more volume than is absorbed through fluid 
ingestion. A primary symptom of poorly managed diabetes with 
hyperglycemia is polydipsia, or excessive thirst. This excessive 
thirst makes reduction of fluid intake (drinking) potentially 
problematic and even adversarial for patients.
This study was an Institutional Review Board approved observational 
and retrospective study. Potential participants were identified during 
their admission on the inpatient Cardiology B unit by charge nurses, 
investigators, and floor nurses. At the time of discharge, these 
participants were invited to complete a five question survey asking 
about the their diabetes and inpatient experience. This survey 
identified participant satisfaction with blood sugar management, 
whether improved sugar control would be preferable, their difficulty 
adhering to the fluid restriction, and whether they utilized oral glycemic 
agents at home. The first four items were addressed with a 5-point 
Likert scale; the oral agents item response choices were Yes and No. 
Investigators then collected clinical data by reviewing electronic 
medical records, specifically gathering data about diagnosis, length of 
stay, creatinine, capillary blood glucose, hga1c,  and nutrition profile. 
This observational and retrospective study was conducted to 
elicit relevant data from known participants admitted for heart 
failure with comorbid data to identify opportunities to improve 
patient outcomes such as adherence to treatment regimens, 
patient satisfaction, renal function and length of stay. This 
study took place at Providence St. Vincent Medical Center’s 
40- bed Cardiology B unit. 
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This study included 7 participants who fit the research criteria. The 
patients’ lengths of stay averaged 8.7 ± 2.1 days and  ranged from 2-
28 days. Blood sugars averaged 164 ±51 and ranged from 80 to 374. 
The participants’ laboratory A1c averaged 7.6 ±2.1 and ranged from 5 
to 11.8, while A1c calculated from median blood sugar was 7.1 ±0.9 
and ranged from 6.9 to 8.2. The participants’ average inpatient blood 
sugars translate to an A1c of 7.5 ± 0.4; excluding one value for one 
patient who had 4 of 5 values nearly identical, the average adjusted 
inpatient blood sugars translate to an A1c of 7.3, reflecting tighter 
blood sugar control as seen in figure 1. 
Creatinine averaged 2.1 ±1.0 from 1.3 to 4.0. 
All 7 participants completed the survey where 5 was the highest score 
on each Likert scale question. A total of 5 (71%) patients reported 
taking oral diabetes medication at home. 
In survey responses, participants expressed a positive view of their 
blood sugar management with 6 (86%) responding they were 
somewhat satisfied or satisfied with their blood sugar management 
with the average being 4.2 out of 5 on the Likert Scale. 
Results
All participants’ median blood sugars after admission reflected a 
median A1c of less than 8.2. Participants’ A1c calculated from 
mean blood sugar averaged 7.6% lower than laboratory and 
change from laboratory to A1c calculated from median blood 
sugars was -11%. As 5 of the 7 patients reported taking oral 
diabetes medication at home, and sliding scale subcutaneous 
insulin was the treatment while inpatient, this change in 
regimen with 4 sliding scale blood sugar readings per day did 
result in increased control. However, both laboratory and 
inpatient blood sugar data reflects sub-optimal blood sugar 
control according to the American Diabetes Association (ADA). 
This may imply the participant plays a larger role in blood sugar 
management than the regimen itself. Dietary and lifestyle 
modifications may demonstrate greater efficacy than 
medication regimen, even while in-patient
Participant laboratory values of A1c reflecting glucose control 
prior to admission and creatinine level were the greatest 
correlators of length of stay. This finding is expected as poor 
blood sugar control is known to have a causal relationship with 
impaired renal function, as reflected by increased creatinine. 
Impaired renal function has been shown to decrease the 
efficacy of diuresis, which would in turn increase length of stay. 
There was some correlation between increased blood sugars 
while inpatient and difficulty abiding fluid restriction as well as 
an increase in number of denied fluid requests. This is 
consistent with polydipsia from hyperglycemia making fluid 
restriction compliance difficult, leading to increased fluid intake 
and increased difficulty abiding a fluid restriction. While the 
strengths of these correlations is weak, it does imply that 
improved inpatient blood sugar control may improve participant 
satisfaction. 
Future investigations would benefit from larger participation 
groups. Updates to expanding unit’s scope of service may 
account for the low study sample, as St. Vincent has increased 
telemetry capacity, and treatment of heart failure populations 
have been redistributed across multiple units outside 
cardiology.
In addition, some attitudes reflect poor insight into diabetes 
control including the clustering of responses around improved 
blood sugar control. Only one participant answered that 
improved blood sugar control would benefit inpatient 
experience “a good amount” and none answered “a great 
amount.” This is despite the mean and median blood sugar 
being 164 and 156 respectively, with the American Diabetes 
Association guidelines indicating 130 as the target blood sugar 
two hours after eating.. 
1 2 3 4 5 6 7
Creatinine 1.26 1.54 1.88 1.48 2.85 1.63 4
Length of Stay 2 5 5 6 7 8 28
Lab a1c 5 7 8 7.8 6.4 6.9 11.8
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Comparison of A1c Values
Laboratory (home) A1c Average A1c Adjusted A1c
Not at All
28%
Just a Little
29%
Somewhat
29%
A Good Amount
14%
Do you believe better blood sugar 
control would improve your hospital 
experience?Easy
0%
Somewhat Easy
28%
Neutral 
29%
Somewhat 
Difficult
29%
Difficult
14%
Please Rate How Easy It Was To Stay 
Below Your Fluid/Water Restriction.
Satisfied
57%
Somewhat 
Satisfied
29%
Neutral
14%
Somewhat 
Unsatisfied
0%
Unsatisfied
0%
Please rate your satisfaction with how 
well your blood sugar or diabetes was 
managed while you were here. 
Never
0%
Once this Stay
28%
Less than Once 
Per Day
29%
Once Per Day
29%
More than Once 
Per Day
14%
Was there a time that a staff member 
would or could not bring fluids because 
of the fluid restriction? 
